Reading time: 5 mins
Written on: 30-03-2026
Fast track | European Heart Journal publication of PIONEER IV confirms QFR-guided PCI matches conventional strategies while reducing procedural complexity
Leiden, The Netherlands – Monday 30th – As momentum builds around angiography-derived physiology following a series of recent clinical trial results presented at ACC, a newly published study in the European Heart Journal adds further reassurance to the field. The interim analysis of the PIONEER IV trial confirms that the MEDIS QFR-guided approach to percutaneous coronary intervention delivers clinical outcomes comparable to conventional strategies, while offering a more streamlined path to treatment.
The PIONEER IV trial ,-sponsored by the University of Galway and its Corelab, (CORRIB lab),supported by MEDIS and funded by Sinomed -,demonstrated that PCI guided by Quantitative Flow Ratio (QFR) is non-inferior to usual-care PCI, including approaches utilizing pressure wires ( in 41 %) with respect to 1-year patient-oriented composite outcomes. Conducted across 26 European sites in an all-comer population, the study showed nearly identical event rates between QFR-guided and conventional strategies at 6.9 percent versus 6.8 percent, with no increase in safety signals such as spontaneous myocardial infarction.
These findings arrive at a pivotal moment for the interventional cardiology community . Following a series of recent clinical readouts that have reassured clinicians of the value of angiography-derived physiology, the PIONEER IV results add another important layer of evidence. They demonstrate not only that angiography-derived physiology is clinically safe, but that it can simplify procedures without compromising outcomes.
Simplifying the Path to Physiology-Guided Care
Despite decades of supporting data, coronary physiology remains underutilized in daily practice, often due to added procedural steps, time pressure, and workflow disruption in the catheterization laboratory. Angiography-derived physiology represents a different approach by embedding functional assessment directly into the angiographic workflow.
PIONEER IV illustrates how this approach translates into practice. QFR enabled both lesion assessment and post-PCI optimization without the routine need for pressure wires or hyperemic agents. Post-PCI physiological assessment identified suboptimal results in a meaningful proportion of cases, enabling targeted optimization within the same procedure.
“PIONEER IV shows that physiology-guided PCI can be both comprehensive and efficient,” said Prof. Patrick W. Serruys, principal investigator of the study. “By integrating physiology directly and systematically into the angiographic workflow, QFR allows clinicians to assess and optimize treatment in real time without adding complexity, which is essential in today’s cath lab environment.”
From Added Steps to Removed Steps
The recent publication from the SCAI expert round table emphasized the growing role of angiography-derived physiology as a versatile and scalable solution in contemporary practice. Rather than adding steps, these technologies have the potential to streamline procedures and make physiological insights more accessible. This perspective is reinforced by the extensive evidence base behind QFR, which continues to be one of the most studied angiography-derived physiology modalities and represents the dominant proportion of the data cited in recent expert opinion papers.
“At Medis, we believe innovation should simplify the way clinicians work, not complicate it,” said Maya Barley, CEO of Medis Medical Imaging. “QFR was developed to remove barriers to physiology by integrating it seamlessly into existing workflows. The results from PIONEER IV reinforce that you can achieve strong clinical outcomes while making procedures more efficient and more accessible to every patient.”
Building Confidence in a New Standard of Care
With accumulating evidence from multiple landmark trials and growing recognition in expert consensus, angiography-derived physiology is moving from alternative to essential. The latest data from PIONEER IV further strengthens the case that a streamlined, physiology-guided approach can deliver both clinical confidence and procedural efficiency in everyday practice.
About Medis Medical Imaging
For over 35 years, Medis has provided innovative and clinically validated software solutions to the cardiovascular imaging community. Medis’ tools are trusted globally by clinicians, researchers, and industry partners to improve diagnostic precision and patient care. With a strong commitment to quality and usability, Medis continues to lead in the advancement of non-invasive cardiovascular imaging.
Media Contact:
Medis Medical Imaging
Regina Beyhl
Head of Marketing
RBeyhl@medisimaging.com
